Axomap

World Model Startups Signals

32 Companies 6 Categories
Connect landscape data to View landscape

Clear applications and early buyer validation exist across several parts of the market. Adoption remains uneven, and repeatable demand is not yet broadly demonstrated across independent providers.

ConfidenceLow

Assessed as of

Current state, informed by 36 months and relevant older history.

Assessment methodology
Supporting sources (9)

Competitive strength is dispersed across providers serving distinct applications. Commercial advantages within individual categories do not establish a dominant group across the broader market.

ConfidenceLow

Assessed as of

Current structure, informed by 24 months.

Assessment methodology
Supporting sources (10)

Substantive technical advances and practical deployment are occurring across several independent parts of the market. Broad commercial effects remain less established than the expansion of capabilities.

ConfidenceMedium

Assessed as of

Rolling six months; no acceleration score.

Assessment methodology
Supporting sources (10)

Venture investment has strengthened exceptionally across the market, with very large increases in several major categories and broader funding activity beyond a single segment.

ConfidenceMedium

Assessed as of

Rolling 12 months versus the preceding 12 months.

Assessment methodology
Supporting sources (17)

Products are broadening beyond prediction into interactive and operational applications. This expansion spans several independent categories rather than a single technical approach.

ConfidenceMedium

Assessed as of

Rolling 12 months.

Assessment methodology
Supporting sources (12)

Documented launches and category entries are widening independent participation across several applications. Consolidation is occurring, but it has not established a broad reduction in participation.

ConfidenceLow

Assessed as of

Rolling 24 months.

Assessment methodology
Supporting sources (12)

General & Spatial Worlds

Commercial adoption is visible in creative media, while interactive world generation remains largely at the preview and early access stage. Repeatable buyer demand is not yet broadly demonstrated across the category.

ConfidenceLow

Assessed as of

Current state, informed by 36 months and relevant older history.

Assessment methodology
Supporting sources (8)

A small commercially proven group coexists with providers whose market presence rests mainly on research previews and early product access. This creates a gap in demonstrated commercial reach.

ConfidenceLow

Assessed as of

Current structure, informed by 24 months.

Assessment methodology
Supporting sources (9)

Consequential changes across independent providers are broadening interactive simulation and bringing spatial capabilities into physical applications. Ownership change is also reshaping the category.

ConfidenceMedium

Assessed as of

Rolling six months; no acceleration score.

Assessment methodology
Supporting sources (10)

Venture investment has strengthened exceptionally in both scale and recipient breadth. The increase extends beyond a single exceptional recipient.

ConfidenceMedium

Assessed as of

Rolling 12 months versus the preceding 12 months.

Assessment methodology
Supporting sources (15)

Products are broadening from generated scenes and video into shared interactive simulation and physical environment reconstruction. Developer access is extending these capabilities into applications beyond standalone demonstrations.

ConfidenceMedium

Assessed as of

Rolling 12 months.

Assessment methodology
Supporting sources (13)

Documented venture launches and new public offerings are increasing independent participation. Acquisition activity is material but has not yet established a broad reduction in participation.

ConfidenceMedium

Assessed as of

Rolling 24 months.

Assessment methodology
Supporting sources (9)
Company Score Movement History
89 +1
82 —
66 —
52 —
38 —

* Company acquired

Robotics & Embodied Intelligence

Clear robotics applications have early buyer validation, but adoption remains uneven. Repeatable demand is not yet broadly demonstrated.

ConfidenceLow

Assessed as of

Current state, informed by 36 months and relevant older history.

Assessment methodology
Supporting sources (5)

Competitive strength appears dispersed across providers addressing different robotics needs. No clear group of dominant providers is established.

ConfidenceLow

Assessed as of

Current structure, informed by 24 months.

Assessment methodology
Supporting sources (8)

Substantive technical development and practical validation are occurring across several independent providers. Investment is also supporting further development.

ConfidenceMedium

Assessed as of

Rolling six months; no acceleration score.

Assessment methodology
Supporting sources (7)

Venture investment has increased substantially from a zero observed baseline. Funding now reaches several independent recipients, although most capital is concentrated in one recipient.

ConfidenceMedium

Assessed as of

Rolling 12 months versus the preceding 12 months.

Assessment methodology
Supporting sources (4)

Embodied world models are broadening from prediction and evaluation into robot control and learning. Capabilities are also extending to more complex autonomous behavior.

ConfidenceMedium

Assessed as of

Rolling 12 months.

Assessment methodology
Supporting sources (6)

New independent offerings are widening participation in robotics evaluation and embodied modeling. Some consolidation is occurring alongside that entry.

ConfidenceLow

Assessed as of

Rolling 24 months.

Assessment methodology
Supporting sources (3)
Company Score Movement History
72 —
32 —
29 —
25 —
19 —

Earth, Energy & Industrial Systems

Clear applications and early buyer validation exist across independent providers. Commercial adoption remains uneven, with broad repeatable demand not yet demonstrated.

ConfidenceLow

Assessed as of

Current state, informed by 36 months and relevant older history.

Assessment methodology
Supporting sources (5)

Competitive strength appears dispersed across providers serving distinct physical applications. No dominant group is clearly established.

ConfidenceLow

Assessed as of

Current structure, informed by 24 months.

Assessment methodology
Supporting sources (9)

Substantive change spans several independent providers. New capabilities and operational deployments are broadening practical use across energy and industry.

ConfidenceMedium

Assessed as of

Rolling six months; no acceleration score.

Assessment methodology
Supporting sources (10)

Venture investment has increased substantially. Funding has also reached a slightly broader set of independent recipients.

ConfidenceMedium

Assessed as of

Rolling 12 months versus the preceding 12 months.

Assessment methodology
Supporting sources (5)

Products are broadening from prediction into operational decision support. Industrial offerings are extending into more deployable applications.

ConfidenceMedium

Assessed as of

Rolling 12 months.

Assessment methodology
Supporting sources (9)

New independent offerings are widening participation. Consolidation remains localized rather than the dominant market direction.

ConfidenceLow

Assessed as of

Rolling 24 months.

Assessment methodology
Supporting sources (4)
Company Score Movement History
57 +2
50 —
38 —
35 —
19 —

Biology

Biological prediction models are reaching commercial use, but buyer adoption remains uneven. Repeatable demand is not yet broadly demonstrated across independent providers.

ConfidenceLow

Assessed as of

Current state, informed by 36 months and relevant older history.

Assessment methodology
Supporting sources (4)

Several providers have meaningful biological modeling capabilities and routes to market. A dominant competitive position has not been established.

ConfidenceLow

Assessed as of

Current structure, informed by 24 months.

Assessment methodology
Supporting sources (5)

Substantive advances are occurring across independent providers. Biological simulation is moving toward broader research use and more practical treatment response prediction.

ConfidenceMedium

Assessed as of

Rolling six months; no acceleration score.

Assessment methodology
Supporting sources (5)

Venture financing continues, but its direction cannot be determined because the current investment amount is undisclosed.

Assessed as of

Rolling 12 months versus the preceding 12 months.

Assessment methodology
Supporting sources (2)

Biological models are broadening into tissue context and cell simulation. Their applications are extending into treatment response prediction and automated model development.

ConfidenceMedium

Assessed as of

Rolling 12 months.

Assessment methodology
Supporting sources (5)

A new independent participant has entered biological modeling. This widens participation, although the breadth of entry remains uncertain.

ConfidenceLow

Assessed as of

Rolling 24 months.

Assessment methodology
Supporting sources (2)
Company Score Movement History
52 —
39 +2
19 —

Society & Human Behavior

Commercial offerings are taking shape, but buyer validation remains isolated. Repeatable demand across independent providers is not yet demonstrated.

ConfidenceLow

Assessed as of

Current state, informed by 36 months and relevant older history.

Assessment methodology
Supporting sources (3)

The distribution of competitive strength cannot be determined without comparable evidence of adoption or commercial scale across providers.

Assessed as of

Current structure, informed by 24 months.

Assessment methodology
Supporting sources (2)

Recent commercial progress is localized, with enterprise demand beginning to surface. Broad market change is not demonstrated.

ConfidenceLow

Assessed as of

Rolling six months; no acceleration score.

Assessment methodology
Supporting sources (1)

Observed venture funding has declined to zero in the latest twelve months from a positive prior period.

ConfidenceMedium

Assessed as of

Rolling 12 months versus the preceding 12 months.

Assessment methodology
Supporting sources (1)

Simulation offerings are broadening from survey prediction toward larger enterprise applications. Supported simulation inputs are also expanding.

ConfidenceLow

Assessed as of

Rolling 12 months.

Assessment methodology
Supporting sources (2)

Independent participation appears broadly stable. A new commercial offering is visible, but there is no clear evidence of additional independent entry or consolidation.

ConfidenceLow

Assessed as of

Rolling 24 months.

Assessment methodology
Supporting sources (1)
Company Score Movement History
42 +7
27 —

World Model Infrastructure

A market assessment has not been run for this landscape yet.

A market assessment has not been run for this landscape yet.

A market assessment has not been run for this landscape yet.

A market assessment has not been run for this landscape yet.

A market assessment has not been run for this landscape yet.

A market assessment has not been run for this landscape yet.

Company Score Movement History
46 —